North America Lipidomics Equipment Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Targeted and Untargeted), Offerings {MS-Based Lipidomics Techniques [Mass Spectrometers Equipped with Ion Sources (Turbo-) ESI/Nano-ESI/APCI, Aut

North America Lipidomics Equipment Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Targeted and Untargeted), Offerings {MS-Based Lipidomics Techniques [Mass Spectrometers Equipped with Ion Sources (Turbo-) ESI/Nano-ESI/APCI, Autosamplers, Micropumps, UV Detectors, UPLC, Variable-Length Fluorescence Detectors, and Others], Assays For Lipid Metabolism, Lipid Flux Using Heavy Isotope-Labeled Precursors, Software & Services, and Others}, Services (Biomarker Identification, Bioinformatic Analysis & Data Interpretation, Molecular Analysis of a Broad Spectrum of Phospholipids (Lipid Fingerprinting), Analysis & Identification of Unusual Lipids, Semiquantitative & Quantitative Analysis, Lipid Flux Studies, and Others), and End User (Molecular Research, Cellular Research, Clinical Research, Tissue & Organ Research, Data Research, Organism Research, Technical Services & Prototyping, Production, and Others)

The North America lipidomics equipment market is expected to grow from US$ 415.85 million in 2022 to US$ 943.65 million by 2028. It is estimated to register a CAGR of 14.6% from 2022 to 2028.

Technological Advancements in Mass Spectrometry Fuels the North America Lipidomics Equipment Market

Mass spectrometers are commonly used for the identification and quantification of lipids. The high-energy collisional-activated dissociation (CAD) technique of mass spectrometry results in charge remote fragmentation (CRF) reactions, which help detect the location of small structural bond details. Several advanced mass spectrometers, including sector mass spectrometry, matrix-assisted laser desorption ionization-time-of-flight (MALDI-TOF), liquid chromatography-mass spectrometry (LC-MS), and tandem mass spectrometer have been made available for researchers and technicians. Further, these instruments are being integrated with automation, miniaturization, artificial intelligence (AI), and smart technologies to enhance their efficiencies and accuracies. In 2018, Thermo Scientific launched Genesys 50 UV/vis spectrometer that has a single-cell configuration for low sample throughput needs, with a removable, washable sampling compartment for easy clean-up. In the same year, Shimadzu, in collaboration with PREMIER Biosoft, launched Shimadzu's LCMS-9030 Quadrupole Time of Flight (Q-TOF) mass spectrometry (MS) system for lipidomics and glycomics data analysis. The product features informatics support powered by software solutions of PREMIER Biosoft. Therefore, the introduction of such new enhanced mass spectrometers and micropumps is boosting the growth of the North America lipidomics equipment market.

North America Lipidomics Equipment Market Overview

The North America lipidomics equipment market has been segmented into the US, Canada, and Mexico. The US held the largest share of the North America lipidomics equipment market in 2022. The market growth in the country is primarily driven by the increasing prevalence of chronic diseases such as cancer. For instance, according to the National Cancer Institute, the country will see 1,735,350 new cancer cases in 2020. Breast cancer, lung and bronchus bronchial cancer, prostate cancer, colon and rectal cancer, melanoma cancer, and liver cancer are the most common types of cancer. The incidence rate of cancer is increasing at an alarming rate in the country, increasing the demand for cancer diagnoses. Increasing investments and rising funds dedicated to the pharma manufacturing companies and academic and research institutes for developing various medicines, the growing geriatric population, increasing incidence of infectious diseases, and other therapeutics are among the major driving factors. Additionally, most foreign companies in the healthcare sector have R&D centers in the United States. Because these facilities rely on lipidomics services to provide high-quality outcomes, this industry is projected to grow rapidly. Chronic illnesses account for seven out of ten fatalities in the United States. Currently, more than half of Americans live with a chronic illness. The incidence of these diseases is expected to reach 170 million in the United States by 2030, boosting the pharmaceutical industry and, in turn, the demand for lipidomics equipment in the country.

North America Lipidomics Equipment Market Revenue and Forecast to 2028 (US$ Million)

North America Lipidomics Equipment Market Segmentation

The North America lipidomics equipment market is segmented based on type, offerings, services, end user, and country.

Based on type, the North America lipidomics equipment market is bifurcated into targeted and untargeted. The targeted segment held a larger market share in 2022.

Based on offerings, the North America lipidomics equipment market is segmented into MS-based lipidomics techniques, assays for lipid metabolism, lipid flux using heavy isotope-labeled precursors, software & services, and others. The MS-based lipidomics techniques segment held the largest market share in 2022. The MS-based lipidomics techniques segment is further categorized into mass spectrometers equipped with ion sources (turbo-) ESI/nano-ESI/APCI, autosamplers, micropumps, UV detectors, UPLC, variable-length fluorescence detectors, and others.

Based on services, the North America lipidomics equipment market has been segmented into biomarker identification, bioinformatic analysis & data interpretation, molecular analysis of a broad spectrum of phospholipids (lipid fingerprinting), analysis & identification of unusual lipids, semiquantitative & quantitative analysis, lipid flux studies, and others. The biomarker identification segment held the largest market share in 2022.

Based on end user, the North America lipidomics equipment market is segmented into molecular research, cellular research, clinical research, tissue & organ research, data research, organism research, technical services & prototyping, production, and others. The molecular research segment held the largest market share in 2022.

Based on country, the North America lipidomics equipment market has been categorized into the US, Canada, and Mexico. Our regional analysis states that the US dominated the market in 2022.

Agilent Technologies, Inc.; Bruker; Cayman Chemical; Creative Proteomics; IonBench; Metabolon, Inc.; PerkinElmer Inc.; Sciex; Shimadzu Corporation.; and Thermo Fisher Scientific Inc. are among the leading companies operating in the North America lipidomics equipment market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America lipidomics equipment market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America lipidomics equipment market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the lipidomics equipment market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution